CRSP logo

CRISPR Therapeutics AG (CRSP) Operating profit

annual operating profit:

-$466.57M-$244.03M(-109.66%)
December 31, 2024

Summary

  • As of today (September 15, 2025), CRSP annual operating income is -$466.57 million, with the most recent change of -$244.03 million (-109.66%) on December 31, 2024.
  • During the last 3 years, CRSP annual operating profit has fallen by -$840.09 million (-224.91%).
  • CRSP annual operating profit is now -224.91% below its all-time high of $373.53 million, reached on December 31, 2021.

Performance

CRSP Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPincome statement metrics

quarterly operating profit:

-$133.07M+$15.35M(+10.34%)
June 30, 2025

Summary

  • As of today (September 15, 2025), CRSP quarterly operating income is -$133.07 million, with the most recent change of +$15.35 million (+10.34%) on June 30, 2025.
  • Over the past year, CRSP quarterly operating profit has increased by +$18.19 million (+12.02%).
  • CRSP quarterly operating profit is now -117.45% below its all-time high of $762.62 million, reached on June 30, 2021.

Performance

CRSP quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPincome statement metrics

TTM operating profit:

-$456.21M+$18.19M(+3.83%)
June 30, 2025

Summary

  • As of today (September 15, 2025), CRSP TTM operating income is -$456.21 million, with the most recent change of +$18.19 million (+3.83%) on June 30, 2025.
  • Over the past year, CRSP TTM operating profit has dropped by -$124.96 million (-37.72%).
  • CRSP TTM operating profit is now -201.85% below its all-time high of $447.92 million, reached on June 30, 2021.

Performance

CRSP TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

CRSP Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-109.7%+12.0%-37.7%
3 y3 years-224.9%+27.4%+28.0%
5 y5 years-1098.2%-64.9%-10000.0%

CRSP Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-224.9%+30.7%-291.2%+27.4%-129.1%+33.6%
5 y5-year-224.9%+30.7%-117.5%+27.4%-201.8%+33.6%
alltimeall time-224.9%+30.7%-117.5%+27.4%-201.8%+33.6%

CRSP Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$133.07M(-10.3%)
-$456.21M(-3.8%)
Mar 2025
-
-$148.42M(+129.8%)
-$474.40M(+1.7%)
Dec 2024
-$466.57M(+109.7%)
-$64.59M(-41.4%)
-$466.56M(+40.4%)
Sep 2024
-
-$110.13M(-27.2%)
-$332.39M(+0.3%)
Jun 2024
-
-$151.26M(+7.6%)
-$331.25M(+20.4%)
Mar 2024
-
-$140.59M(-302.0%)
-$275.22M(+38.2%)
Dec 2023
-$222.54M(-66.9%)
$69.58M(-163.8%)
-$199.12M(-50.3%)
Sep 2023
-
-$108.99M(+14.5%)
-$400.24M(-15.5%)
Jun 2023
-
-$95.22M(+47.7%)
-$473.64M(-15.7%)
Mar 2023
-
-$64.49M(-51.0%)
-$561.68M(-16.6%)
Dec 2022
-$673.16M(-280.2%)
-$131.54M(-27.9%)
-$673.16M(-2.1%)
Sep 2022
-
-$182.39M(-0.5%)
-$687.32M(+8.4%)
Jun 2022
-
-$183.26M(+4.1%)
-$633.78M(-303.1%)
Mar 2022
-
-$175.97M(+20.8%)
$312.10M(-16.4%)
Dec 2021
$373.53M(-205.4%)
-$145.70M(+13.1%)
$373.53M(-9.2%)
Sep 2021
-
-$128.85M(-116.9%)
$411.46M(-8.1%)
Jun 2021
-
$762.62M(-765.8%)
$447.92M(-213.3%)
Mar 2021
-
-$114.54M(+6.3%)
-$395.39M(+11.6%)
Dec 2020
-$354.44M
-$107.76M(+16.6%)
-$354.44M(+50.4%)
Sep 2020
-
-$92.40M(+14.5%)
-$235.69M(+5608.2%)
Jun 2020
-
-$80.69M(+9.7%)
-$4.13M(-119.1%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$73.59M(-770.0%)
$21.58M(-53.8%)
Dec 2019
$46.74M(-129.4%)
$10.98M(-92.1%)
$46.74M(-593.5%)
Sep 2019
-
$139.16M(-353.1%)
-$9.47M(-95.2%)
Jun 2019
-
-$54.98M(+13.5%)
-$198.07M(+9.8%)
Mar 2019
-
-$48.42M(+7.1%)
-$180.37M(+13.5%)
Dec 2018
-$158.94M(+145.9%)
-$45.23M(-8.5%)
-$158.94M(+41.0%)
Sep 2018
-
-$49.43M(+32.6%)
-$112.74M(+29.8%)
Jun 2018
-
-$37.29M(+38.1%)
-$86.88M(+22.5%)
Mar 2018
-
-$27.00M(-2877.5%)
-$70.90M(+9.7%)
Dec 2017
-$64.65M(-5.1%)
$972.00K(-104.1%)
-$64.65M(-28.9%)
Sep 2017
-
-$23.57M(+10.6%)
-$90.93M(+10.9%)
Jun 2017
-
-$21.31M(+2.7%)
-$81.97M(+6.1%)
Mar 2017
-
-$20.74M(-18.0%)
-$77.22M(+13.3%)
Dec 2016
-$68.13M(+164.8%)
-$25.31M(+73.2%)
-$68.13M(+59.1%)
Sep 2016
-
-$14.61M(-11.8%)
-$42.82M(+51.8%)
Jun 2016
-
-$16.56M(+42.1%)
-$28.21M(+84.7%)
Mar 2016
-
-$11.65M(+221.4%)
-$15.28M(+107.5%)
Dec 2015
-$25.73M(+288.2%)
-
-
Jun 2015
-
-$3.63M(-3.0%)
-$7.36M(+97.0%)
Mar 2015
-
-$3.74M
-$3.74M
Dec 2014
-$6.63M
-
-

FAQ

  • What is CRISPR Therapeutics AG annual operating income?
  • What is the all time high annual operating profit for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG annual operating profit year-on-year change?
  • What is CRISPR Therapeutics AG quarterly operating income?
  • What is the all time high quarterly operating profit for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG quarterly operating profit year-on-year change?
  • What is CRISPR Therapeutics AG TTM operating income?
  • What is the all time high TTM operating profit for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG TTM operating profit year-on-year change?

What is CRISPR Therapeutics AG annual operating income?

The current annual operating profit of CRSP is -$466.57M

What is the all time high annual operating profit for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high annual operating income is $373.53M

What is CRISPR Therapeutics AG annual operating profit year-on-year change?

Over the past year, CRSP annual operating income has changed by -$244.03M (-109.66%)

What is CRISPR Therapeutics AG quarterly operating income?

The current quarterly operating profit of CRSP is -$133.07M

What is the all time high quarterly operating profit for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high quarterly operating income is $762.62M

What is CRISPR Therapeutics AG quarterly operating profit year-on-year change?

Over the past year, CRSP quarterly operating income has changed by +$18.19M (+12.02%)

What is CRISPR Therapeutics AG TTM operating income?

The current TTM operating profit of CRSP is -$456.21M

What is the all time high TTM operating profit for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high TTM operating income is $447.92M

What is CRISPR Therapeutics AG TTM operating profit year-on-year change?

Over the past year, CRSP TTM operating income has changed by -$124.96M (-37.72%)
On this page